Telix is commercialising its therapeutic and diagnostic radiopharmaceuticals. Its share price has more than doubled in 2024, and the company now has a market capitalisation of almost $6.4 billion. …
Telix completes significant raise that could be used for acquisitions
July 25, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Just because the system involves humans, it does not make it human
August 14, 2025 - - Latest News -
Australian company Mirugen secures backing to process cell technology
August 13, 2025 - - Latest News -
AccessCR’s awards celebrate partnerships between lived experience and science
August 13, 2025 - - Latest News -
Firebrick says Nasodine COVID-19 patent accepted in Europe
August 13, 2025 - - Australian Biotech -
Orthocell advances US rollout of nerve repair product Remplir
August 13, 2025 - - Australian Biotech -
AVITA Medical successfully completes Australian equity raise
August 13, 2025 - - Australian Biotech -
Experienced innovation leader joins AusBiotech as its Head of Investment
August 13, 2025 - - Australian Biotech